Madrigal Pharmaceuticals(MDGL) - 2022 Q1 - Earnings Call Transcript

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2022 Results Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Paul Friedman - Chairman and Chief Executive Officer Rebecca Taub - Founder, Chief Medical Officer and President of Research & Development Remy Sukhija - Chief Commercial Officer Alex Howarth - Chief Financial Officer Stephen Harrison - M.D., Medical Director, Pinnacle Clinical Research Conference Call Participants Ritu Baral - Cowen Thomas Smith - SVB Securities Yasmeen Rahimi - ...